HR 5979
109th Congress
House
Health
Commerce
Conflict of interests
Consumer education
Drug industry
Drugs
Finance and Financial Sector
Fines (Penalties)
Government Operations and Politics
Government paperwork
Informed consent (Medical law)
Law
Medical ethics
Pharmacies
Prescription pricing
Pharmaceutical Benefit Manager Abuse Prevention Act of 2006
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 1, 2006
Referred to the Subcommittee on Health.
Jul 28, 2006
Referred to the House Committee on Energy and Commerce.
Jul 28, 2006
Introduced in House
Plain-English summary
Pharmaceutical Benefit Manager Abuse Prevention Act of 2006 - Prohibits a pharmaceutical benefit manager from: (1) referring a patient to a pharmacy or other dispenser of pharmaceuticals that is owned or affiliated with the manager; or (2) changing the drug authorization for a patient without the patient's express consent and without informing the patient of the financial consequences.
Requires each pharmaceutical benefit manger to publicly disclose any kickbacks or other financial incentives or any relationship with any pharmaceutical manager.
Provides for civil penalties for violations.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2